company background image
002262 logo

Jiangsu Nhwa Pharmaceutical SZSE:002262 Stock Report

Last Price

CN¥23.37

Market Cap

CN¥23.9b

7D

5.1%

1Y

-17.3%

Updated

23 Jul, 2024

Data

Company Financials +

Jiangsu Nhwa Pharmaceutical Co., LTD

SZSE:002262 Stock Report

Market Cap: CN¥23.9b

002262 Stock Overview

Engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally.

002262 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends5/6

Jiangsu Nhwa Pharmaceutical Co., LTD Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jiangsu Nhwa Pharmaceutical
Historical stock prices
Current Share PriceCN¥23.37
52 Week HighCN¥29.42
52 Week LowCN¥20.64
Beta0.011
11 Month Change-1.52%
3 Month Change-2.50%
1 Year Change-17.30%
33 Year Change73.88%
5 Year Change94.59%
Change since IPO1,260.10%

Recent News & Updates

Recent updates

Here's Why Jiangsu Nhwa Pharmaceutical (SZSE:002262) Has Caught The Eye Of Investors

Jul 22
Here's Why Jiangsu Nhwa Pharmaceutical (SZSE:002262) Has Caught The Eye Of Investors

Jiangsu Nhwa Pharmaceutical (SZSE:002262) Seems To Use Debt Rather Sparingly

Jun 16
Jiangsu Nhwa Pharmaceutical (SZSE:002262) Seems To Use Debt Rather Sparingly

Jiangsu Nhwa Pharmaceutical Co., LTD's (SZSE:002262) Share Price Is Matching Sentiment Around Its Earnings

May 09
Jiangsu Nhwa Pharmaceutical Co., LTD's (SZSE:002262) Share Price Is Matching Sentiment Around Its Earnings

Jiangsu Nhwa Pharmaceutical (SZSE:002262) Ticks All The Boxes When It Comes To Earnings Growth

Apr 18
Jiangsu Nhwa Pharmaceutical (SZSE:002262) Ticks All The Boxes When It Comes To Earnings Growth

Earnings Update: Jiangsu Nhwa Pharmaceutical Co., LTD (SZSE:002262) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Apr 02
Earnings Update: Jiangsu Nhwa Pharmaceutical Co., LTD (SZSE:002262) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Shareholder Returns

002262CN PharmaceuticalsCN Market
7D5.1%3.0%0.5%
1Y-17.3%-13.4%-16.6%

Return vs Industry: 002262 underperformed the CN Pharmaceuticals industry which returned -13.4% over the past year.

Return vs Market: 002262 matched the CN Market which returned -16.6% over the past year.

Price Volatility

Is 002262's price volatile compared to industry and market?
002262 volatility
002262 Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 002262 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002262's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19785,394Jiaquan Sunwww.nhwa-group.com

Jiangsu Nhwa Pharmaceutical Co., LTD engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally. The company’s products are used for treatment of anesthesia, analgesia, mental and neurological diseases, narcotic, psychiatry, and neurological categories, as well as APIs. It sells its products through hospitals, private hospitals, online pharmacies, and chain pharmacies.

Jiangsu Nhwa Pharmaceutical Co., LTD Fundamentals Summary

How do Jiangsu Nhwa Pharmaceutical's earnings and revenue compare to its market cap?
002262 fundamental statistics
Market capCN¥23.87b
Earnings (TTM)CN¥1.07b
Revenue (TTM)CN¥5.22b

21.9x

P/E Ratio

4.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002262 income statement (TTM)
RevenueCN¥5.22b
Cost of RevenueCN¥1.49b
Gross ProfitCN¥3.73b
Other ExpensesCN¥2.66b
EarningsCN¥1.07b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 31, 2024

Earnings per share (EPS)1.07
Gross Margin71.55%
Net Profit Margin20.59%
Debt/Equity Ratio1.0%

How did 002262 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

30%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.